These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8790141)

  • 1. BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias.
    Kaukonen J; Lahtinen I; Laine S; Alitalo K; Palotie A
    Br J Haematol; 1996 Sep; 94(3):455-60. PubMed ID: 8790141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
    Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
    Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
    Oncogene; 2000 Aug; 19(36):4151-8. PubMed ID: 10962576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.
    Tamagnone L; Lahtinen I; Mustonen T; Virtaneva K; Francis F; Muscatelli F; Alitalo R; Smith CI; Larsson C; Alitalo K
    Oncogene; 1994 Dec; 9(12):3683-8. PubMed ID: 7970727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells.
    Rizzi M; Tschan MP; Britschgi C; Britschgi A; Hügli B; Grob TJ; Leupin N; Mueller BU; Simon HU; Ziemiecki A; Torbett BE; Fey MF; Tobler A
    J Leukoc Biol; 2007 Jun; 81(6):1599-608. PubMed ID: 17347302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.
    Møller GM; Frost V; Melo JV; Chantry A
    FEBS Lett; 2007 Apr; 581(7):1329-34. PubMed ID: 17349636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.
    Dylla SJ; Deyle DR; Theunissen K; Padurean AM; Verfaillie CM
    Exp Hematol; 2004 Apr; 32(4):365-74. PubMed ID: 15050747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-specificity phosphatase Pyst2-L is constitutively highly expressed in myeloid leukemia and other malignant cells.
    Levy-Nissenbaum O; Sagi-Assif O; Kapon D; Hantisteanu S; Burg T; Raanani P; Avigdor A; Ben-Bassat I; Witz IP
    Oncogene; 2003 Oct; 22(48):7649-60. PubMed ID: 14576828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
    Cilloni D; Messa F; Gottardi E; Fava M; Arruga F; Defilippi I; Carturan S; Messa E; Morotti A; Giugliano E; Rege-Cambrin G; Alberti D; Baccarani M; Saglio G
    Cancer; 2004 Sep; 101(5):979-88. PubMed ID: 15329907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
    Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
    Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.